The pharmaceutical marketplace can be expected to be significantly reshaped with a stronger focus on value and a need for a more complete package of products and services. At Cirio we advise organizations in the drug development phase and later throughout the actual product life cycle, to meet the current challenges and seize on opportunities. Cirio’s experienced pharmaceuticals experts understands the unique risks and challenges faced by pharmaceutical industry participants, such as drug safety and efficacy, clinical trial and commercialization matters, IP protection, pricing and reimbursement, as well as regulatory approval and compliance. Cirio is also uniquely qualified to assist in transactional matters involving pharmaceutical development/products such as seed/venture capital financing, M&A, partnering/licensing arrangements, IPO’s, and public take overs.